COVID-19 mRNA vaccine (ACM Biosciences)

N/A

Report date: 2025/06/13 14:51:40

Base Information

Drug NameCOVID-19 mRNA vaccine (ACM Biosciences)
Drug Alias NamemRNA COVID-19 vaccines
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesACM Biosciences AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnosuisse - Suisse Innovation AgencyACM Biosciences AG
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A